Susquehanna International Group’s CHELSEA THERAPEUTICS INT'L LTD CHTP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
Sell
-396,300
Closed -$2.58M 10581
2014
Q2
$2.58M Sell
396,300
-390,700
-50% -$2.31M ﹤0.01% 4172
2014
Q1
$4.34M Buy
787,000
+207,100
+36% +$1.04M ﹤0.01% 3079
2013
Q4
$2.57M Buy
579,900
+412,200
+246% +$1.39M ﹤0.01% 3865
2013
Q3
$501K Buy
167,700
+87,200
+108% +$250K ﹤0.01% 6421
2013
Q2
$185K Buy
+80,500
New +$163K ﹤0.01% 7498

Susquehanna International Group's CHTP Position: Q2 2014 in Review

Susquehanna International Group sold out of CHELSEA THERAPEUTICS INT'L LTD (CHTP) in Q2 2014, closing a stake of 403,632 shares — an estimated $2.38M sold.

Susquehanna International Group first reported a position in CHTP in Q2 2013 and held it in 4 quarters. The position peaked at $2.23M in Q1 2014. 6 funds tracked by Wall St. Rank hold CHTP as of Q2 2014.

  • Susquehanna International Group reported no remaining CHELSEA THERAPEUTICS INT'L LTD position as of Q2 2014 after selling out during the quarter.
  • Susquehanna International Group sold 403,632 CHELSEA THERAPEUTICS INT'L LTD shares in Q2 2014, an estimated $2.38M.
  • Susquehanna International Group first reported a position in CHELSEA THERAPEUTICS INT'L LTD in Q2 2013 and held it in 4 quarters.
  • Susquehanna International Group's CHELSEA THERAPEUTICS INT'L LTD position peaked at $2.23M in Q1 2014.
  • 6 funds tracked by Wall St. Rank held CHELSEA THERAPEUTICS INT'L LTD as of Q2 2014.

Based on Susquehanna International Group's 13F filing for Q2 2014, filed 14 Aug 2014.